Please use this identifier to cite or link to this item:
/library/oar/handle/123456789/139309| Title: | ±«²Ô»å±ð°ù²õ³Ù²¹²Ô»å¾±²Ô²µ³æ20;»å´Ç±è²¹³¾¾±²Ô±ð’s³æ20;°ù´Ç±ô±ð³æ20;¾±²Ô³æ20;²Ô±ð³Ü°ù´Ç±ô´Ç²µ¾±³¦²¹±ô³æ20;²¹²Ô»å³æ20;±è²õ²â³¦³ó¾±²¹³Ù°ù¾±³¦³æ20;»å¾±²õ´Ç°ù»å±ð°ù²õ |
| Authors: | Blundell, Renald Arslan, Lara |
| Keywords: | Dopamine Neurotransmitters Parkinson's disease Schizophrenia -- Pathophysiology Bipolar disorder -- Pathophysiology Movement disorders -- Treatment |
| Issue Date: | 2025-09 |
| Publisher: | Standard Publications Ltd. |
| Citation: | Blundell, R., & Arslan, L. (2025, September 28). ±«²Ô»å±ð°ù²õ³Ù²¹²Ô»å¾±²Ô²µ³æ20;»å´Ç±è²¹³¾¾±²Ô±ð’s³æ20;°ù´Ç±ô±ð³æ20;¾±²Ô³æ20;²Ô±ð³Ü°ù´Ç±ô´Ç²µ¾±³¦²¹±ô³æ20;²¹²Ô»å³æ20;±è²õ²â³¦³ó¾±²¹³Ù°ù¾±³¦³æ20;»å¾±²õ´Ç°ù»å±ð°ù²õ. The Malta Independent on Sunday, p. 22. |
| Abstract: | Dopamine, a key neurotransmitter in the brain, plays a vital role in regulating movement, emotion, and cognition. It is central to the pathology of several major neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, and bipolar disorder. These conditions, though distinct in their symptoms and progression, share a common feature: the disruption of dopamine signalling pathways. Understanding how dopamine dysfunction contributes to these disorders provides insight into their underlying mechanisms and guides the development of effective treatments. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/139309 |
| Appears in Collections: | Scholarly Works - FacM&SPB |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ±«²Ô»å±ð°ù²õ³Ù²¹²Ô»å¾±²Ô²µ³å»å´Ç±è²¹³¾¾±²Ô±ð’s³å°ù´Ç±ô±ð³å¾±²Ô³å²Ô±ð³Ü°ù´Ç±ô´Ç²µ¾±³¦²¹±ô³å²¹²Ô»å³å±è²õ²â³¦³ó¾±²¹³Ù°ù¾±³¦³å»å¾±²õ´Ç°ù»å±ð°ù²õ(2025).±è»å´Ú | 501.71 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.
